Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 5 | 2023 | 292 | 0.600 |
Why?
|
| Safety Management | 1 | 2008 | 51 | 0.280 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 262 | 0.260 |
Why?
|
| Smartphone | 2 | 2017 | 52 | 0.250 |
Why?
|
| Trees | 1 | 2025 | 46 | 0.220 |
Why?
|
| Emphysema | 1 | 2023 | 24 | 0.190 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 43 | 0.190 |
Why?
|
| Asthma | 3 | 2025 | 1039 | 0.180 |
Why?
|
| Muscle, Smooth | 4 | 2010 | 300 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 481 | 0.170 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 210 | 0.160 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2020 | 54 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2585 | 0.150 |
Why?
|
| Mediastinum | 1 | 2019 | 43 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2020 | 237 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2017 | 1090 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 219 | 0.130 |
Why?
|
| Serum Response Factor | 2 | 2010 | 42 | 0.130 |
Why?
|
| Remote Sensing Technology | 1 | 2017 | 10 | 0.130 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 152 | 0.130 |
Why?
|
| Professional Misconduct | 1 | 2017 | 22 | 0.130 |
Why?
|
| Walk Test | 1 | 2017 | 31 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 32 | 0.130 |
Why?
|
| Internal Medicine | 2 | 2017 | 336 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 155 | 0.120 |
Why?
|
| Lung | 2 | 2023 | 1366 | 0.120 |
Why?
|
| Video Recording | 2 | 2017 | 212 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 44 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2017 | 78 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2019 | 548 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2017 | 296 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2017 | 283 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1713 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 306 | 0.100 |
Why?
|
| Education | 1 | 2013 | 59 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 79 | 0.090 |
Why?
|
| Hospitalization | 1 | 2018 | 937 | 0.090 |
Why?
|
| Humans | 19 | 2025 | 93515 | 0.090 |
Why?
|
| Hospitalists | 1 | 2013 | 136 | 0.080 |
Why?
|
| Physicians | 1 | 2017 | 682 | 0.080 |
Why?
|
| Aged | 7 | 2022 | 20434 | 0.080 |
Why?
|
| Male | 9 | 2025 | 44557 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2025 | 624 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2022 | 423 | 0.070 |
Why?
|
| Disease Progression | 2 | 2025 | 1531 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2013 | 822 | 0.070 |
Why?
|
| Support Vector Machine | 2 | 2017 | 24 | 0.060 |
Why?
|
| Spirometry | 2 | 2017 | 77 | 0.060 |
Why?
|
| Middle Aged | 6 | 2022 | 27573 | 0.060 |
Why?
|
| Female | 8 | 2025 | 48702 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2010 | 603 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 7061 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2025 | 212 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2023 | 31 | 0.050 |
Why?
|
| Actins | 2 | 2003 | 467 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 73 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 3054 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 87 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10164 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 962 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 42 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2003 | 256 | 0.050 |
Why?
|
| Prone Position | 1 | 2022 | 61 | 0.040 |
Why?
|
| Bronchi | 1 | 2003 | 225 | 0.040 |
Why?
|
| Wakefulness | 1 | 2022 | 131 | 0.040 |
Why?
|
| Chicago | 1 | 2025 | 1464 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 402 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 1301 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1729 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2025 | 3829 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 178 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 27918 | 0.030 |
Why?
|
| Oxygen | 1 | 2022 | 769 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 273 | 0.030 |
Why?
|
| Hypoxia | 1 | 2022 | 675 | 0.030 |
Why?
|
| Genome, Human | 1 | 2002 | 823 | 0.030 |
Why?
|
| Accelerometry | 1 | 2017 | 48 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 1001 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1050 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 873 | 0.030 |
Why?
|
| Walking | 1 | 2017 | 104 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 985 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7622 | 0.030 |
Why?
|
| Outpatients | 1 | 2016 | 104 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1948 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1243 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1917 | 0.030 |
Why?
|
| Child | 1 | 2025 | 7355 | 0.030 |
Why?
|
| Educational Technology | 1 | 2013 | 17 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1922 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 9606 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 2544 | 0.020 |
Why?
|
| Curriculum | 1 | 2016 | 594 | 0.020 |
Why?
|
| Dogs | 2 | 2003 | 634 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3911 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 148 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 136 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 394 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 6930 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 309 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 9099 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 436 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 555 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2802 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1117 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2003 | 2850 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1534 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2464 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 1768 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 12 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2003 | 15 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2003 | 16 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 61 | 0.010 |
Why?
|
| Amides | 1 | 2003 | 54 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 116 | 0.010 |
Why?
|
| Elasticity | 1 | 2003 | 98 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2003 | 86 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 124 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2003 | 98 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 112 | 0.010 |
Why?
|
| Trachea | 1 | 2003 | 245 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 161 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 384 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 352 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 269 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 303 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 392 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 219 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 450 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 641 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4272 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1914 | 0.010 |
Why?
|
| Animals | 3 | 2003 | 28155 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 893 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2220 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 2910 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 3502 | 0.010 |
Why?
|